Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence

Study Identifier
192024-032
CT.gov Identifier
NCT00693420
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Hypotrichosis
    • Study Drug
  • Bimatoprost 0.03% sterile solution
  • vehicle sterile solution
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Dissatisfaction with eyelash prominence, * Eyelash prominence assessment of minimal or moderate, * Ability to provide written informed consent
    Exclusion Criteria:
    * Subjects without visible lashes, * Asymmetrical (uneven lashes or longer on one side than the other) eyelashes, * Any eye disease or abnormality, * Eye surgery, * Permanent eyeliner, * Eyelash implants, * Eyelash extension application, * Any use of eyelash growth products within 6 months of study entry, * Treatments that may effect hair growth, * Subjects requiring eye drop medications for glaucoma, * Subjects having a situation or condition, which the study doctor feels might put you at risk, may make the study results confusing, or may interfere with the study.

    Protocol Summary

    This study evaluates the safety and effectiveness of topical bimatoprost solution for enhancing eyelash prominence.

    Study Locations

    Location
    Status
    Location
    San Diego, California, United States
    Status
    Not applicable
    Location
    Vancouver, British Columbia, Canada
    Status
    Not applicable